Regulator of G-protein signaling 5
Regulator of G-protein signaling 5 (74-83) is a synthetic peptide fragment derived from the C-terminal region of the RGS5 protein, a member of the regulator of G-protein signaling family. This peptide encompasses amino acids 74 through 83 of the human RGS5 sequence, a domain implicated in modulating G-protein-coupled receptor (GPCR) signaling pathways. By mimicking a specific segment of the native protein, it serves as a valuable molecular tool for dissecting the structural and functional roles of RGS5 in cellular signaling. Its sequence specificity and biochemical properties make it highly relevant for research focused on signal transduction, protein-protein interactions, and the regulatory mechanisms governing G-protein activity in physiological and pathophysiological contexts.
Signal transduction studies: Researchers utilize this peptide fragment to investigate the mechanisms by which RGS5 modulates GPCR signaling. By introducing the 74-83 sequence into in vitro or cell-based systems, it is possible to study the peptide's capacity to compete with endogenous RGS5 for binding partners or to interfere with G-protein deactivation rates. Such experiments provide insight into how specific domains within RGS proteins influence the kinetics and fidelity of signal transduction, thereby informing broader understanding of cellular communication networks.
Protein interaction assays: The 74-83 peptide is often employed to map and characterize protein-protein interactions involving RGS5. By serving as a binding probe or competitive inhibitor in pull-down assays, co-immunoprecipitation, or surface plasmon resonance studies, it enables researchers to delineate the molecular interfaces between RGS5 and its interacting partners. These applications are critical for identifying the functional consequences of domain-specific interactions, which may affect downstream signaling pathways or regulatory feedback loops.
Functional domain analysis: As a defined peptide corresponding to a specific region of RGS5, the 74-83 fragment is instrumental in structure-function studies. Site-directed mutagenesis or peptide substitution experiments using this sequence can clarify the contribution of the 74-83 domain to the overall regulatory activity of RGS5. Such approaches help elucidate the structural determinants required for GTPase-activating protein (GAP) function and refine models of RGS-mediated signal attenuation.
Cell signaling modulation: In cellular models, exogenous application of the 74-83 peptide allows for the selective modulation of endogenous signaling pathways. By interfering with native protein interactions or altering the localization of signaling complexes, the peptide can be used to probe the consequences of RGS5 domain disruption on cell physiology. These studies are particularly useful for identifying context-dependent roles of RGS5 in processes such as cell migration, proliferation, or stress response.
Peptide-based inhibitor development: The defined nature of the 74-83 sequence provides a template for the rational design of peptide-based inhibitors targeting RGS5 or related signaling components. By serving as a lead structure for optimization, the peptide can guide the development of more potent or selective modulators of G-protein signaling. Such efforts are valuable for advancing chemical biology strategies aimed at dissecting RGS protein function or for generating research tools to manipulate GPCR pathways in model systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More